COMMON STOCK PURCHASE WARRANT BIOSTAGE, INC.Biostage, Inc. • August 17th, 2017 • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, First Pecos, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is six months after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Biostage, Inc., a Delaware corporation (the “Company”), up to 9,700,000 shares (as subject to limitations and adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 17th, 2017 • Biostage, Inc. • Surgical & medical instruments & apparatus • Texas
This Securities Purchase Agreement (this “Agreement”) is dated as of August 11, 2017, between Biostage, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
AMENDMENT NO. 2 TO SHAREHOLDER RIGHTS AGREEMENTShareholder Rights Agreement • August 17th, 2017 • Biostage, Inc. • Surgical & medical instruments & apparatus • Delaware
This Amendment No. 2 to Shareholder Rights Agreement (this “Amendment”) is entered into as of August 14, 2017, between Biostage, Inc., formerly known as Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and Computershare Trust Company, N.A., a federally chartered trust company (as successor rights agent to Registrar and Transfer Company, a New Jersey corporation) (the “Rights Agent”).
